These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

983 related items for PubMed ID: 11751372

  • 21. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 22. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.
    Lee WH, Isaacs WB, Bova GS, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):443-50. PubMed ID: 9184779
    [Abstract] [Full Text] [Related]

  • 23. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.
    Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747
    [Abstract] [Full Text] [Related]

  • 24. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D.
    Clin Cancer Res; 2001 Sep 01; 7(9):2727-30. PubMed ID: 11555585
    [Abstract] [Full Text] [Related]

  • 25. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
    Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG.
    Int J Oncol; 2000 Apr 01; 16(4):663-76. PubMed ID: 10717233
    [Abstract] [Full Text] [Related]

  • 26. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J, Lee HS, Bae SI, Lee YM, Kim WH.
    Anticancer Res; 2005 Apr 01; 25(6B):4013-9. PubMed ID: 16309193
    [Abstract] [Full Text] [Related]

  • 27. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
    Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG.
    Cancer Res; 1998 Oct 15; 58(20):4515-8. PubMed ID: 9788592
    [Abstract] [Full Text] [Related]

  • 28. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma.
    Chu DC, Chuang CK, Fu JB, Huang HS, Tseng CP, Sun CF.
    J Urol; 2002 Apr 15; 167(4):1854-8. PubMed ID: 11912447
    [Abstract] [Full Text] [Related]

  • 29. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.
    Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD, Kensler TW.
    Ann N Y Acad Sci; 2001 Dec 15; 952():135-44. PubMed ID: 11795433
    [Abstract] [Full Text] [Related]

  • 30. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T, Schnekenburger M, Ghelfi J, Walter J, Dicato M, Diederich M.
    Biochem Pharmacol; 2011 Jun 01; 81(11):1329-42. PubMed ID: 21453686
    [Abstract] [Full Text] [Related]

  • 31. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M.
    Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910
    [Abstract] [Full Text] [Related]

  • 32. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP.
    Cancer Res; 2000 Aug 01; 60(15):4044-8. PubMed ID: 10945606
    [Abstract] [Full Text] [Related]

  • 33. Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide.
    Hauptstock V, Kuriakose S, Schmidt D, Düster R, Müller SC, von Ruecker A, Ellinger J.
    Biochem Biophys Res Commun; 2011 Sep 09; 412(4):606-11. PubMed ID: 21855532
    [Abstract] [Full Text] [Related]

  • 34. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR.
    Nat Genet; 2003 Jan 09; 33(1):61-5. PubMed ID: 12496760
    [Abstract] [Full Text] [Related]

  • 35. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 36. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.
    Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG, De Marzo AM.
    Am J Pathol; 2003 Sep 29; 163(3):923-33. PubMed ID: 12937133
    [Abstract] [Full Text] [Related]

  • 37. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.
    Cancer Res; 2008 Jun 01; 68(11):4123-32. PubMed ID: 18519671
    [Abstract] [Full Text] [Related]

  • 38. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M.
    Oncogene; 2002 Aug 12; 21(35):5427-40. PubMed ID: 12154405
    [Abstract] [Full Text] [Related]

  • 39. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 40. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N.
    Cancer Res; 1998 Dec 01; 58(23):5310-4. PubMed ID: 9850055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.